Jianhua Lin

Jianhua Lin


Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in International Journal of Medical Sciences
Verified
Journal Article
Open access
WZWei-Xiu Zhao
Wei-Xiu Zhao
JLJianhua Lin
Jianhua Lin
Notch signaling was evolutionarily conserved and critical for cell-fate determination, differentiation and many other biological processes. Growing evidences suggested that Notch signaling pathway played an important role in the mammalian placental development. All of the mammalian Notch family proteins had been identified in human placenta except Delta-like 3, which appeared to affect the axial skeletal system. However the molecular mechanisms that regulated the Notch signaling pathway remained largely unknown in human placenta. Therefore, additional research was needed to investigate expression pattern of Notch family members and the mechanisms for activation of Notch signaling pathway in human placenta, which might help elucidate the roles of Notch signaling pathway in human placentation. This review would focus on the roles of Notch receptors and ligands in the human placental trophoblasts function and placental angiogenesis. It might hopefully provide perspectives for future research about human placentation of pregnancy complicated by preeclampsia and other placenta associated diseases.

30 April 2018 in The Journal of Clinical Hypertension
Verified
Journal Article
Closed access
PDF file
XLXun Li
Xun Li
WZWeishe Zhang
Weishe Zhang
JLJianhua Lin
Jianhua Lin
HLHuai Liu
Huai Liu
ZYZujing Yang
Zujing Yang
LXLu Xia
Lu Xia

1 July 2018 in Pregnancy Hypertension
Verified
Journal Article
Closed access
XLXun Li
Xun Li
WZWeishe Zhang
Weishe Zhang
JLJianhua Lin
Jianhua Lin
HLHuai Liu
Huai Liu
ZYZujing Yang
Zujing Yang
JZJiejie Zhang
Jiejie Zhang

1 June 2014 in Reproductive Sciences
Verified
Journal Article
Closed access
PDF file
WZWei-Xiu Zhao
Wei-Xiu Zhao
THTao-Tao Huang
Tao-Tao Huang
MJMeng Jiang
Meng Jiang
RFRan Feng
Ran Feng
JLJianhua Lin
Jianhua Lin

31 March 2021 in The Journal of Clinical Hypertension
Verified
Journal Article
Open access
PDF file
XLXin Lyu
Xin Lyu
WZWeiyuan Zhang
Weiyuan Zhang
JZJingxiao Zhang
Jingxiao Zhang
YWYuqian Wei
Yuqian Wei
XGXiaoli Guo
Xiaoli Guo
JLJianhua Lin
Jianhua Lin
Hypertensive disorder in pregnancy is a disease that occurs during pregnancy. We aimed to analyze the morbidity and maternal and infant outcomes with respect to the hypertensive disorder in pregnancy in China in 2018. Clinical data of 38 590 cases from 161 hospitals were retrospectively collected. The differences in morbidity and maternal and infant mortality among the major regions and provinces were compared. The overall national average morbidity was 4.74%, and the ratios of gestational hypertension, preeclampsia, eclampsia, chronic hypertension, and chronic hypertension with superimposed preeclampsia were 29.17%, 55.02%, 0.66%, 6.53%, and 8.62%, respectively. The overall maternal mortality was 0.61/100 000, and the case fatality was 0.13%. Morbidity associated with hypertensive disorder in pregnancy was 7.74% in North China, 6.62% in Northwest China, 6.40% in Central China, 5.83% in Northeast China, 4.28% in East China, 3.85% in South China, and 2.88% in Southwest China. The morbidity in each province was 1.62‐11.28%. The overall perinatal mortality was 3.59% (81.09% for stillbirths; 18.91% for neonatal deaths). Perinatal mortality decreased with increasing gestational weeks from 24 to 37 + 6 weeks. Perinatal mortality for delivery at 32 weeks of gestation in all regions of the country was <10%. Morbidity varied across regions in China, with the lowest in Southwest and the highest in North China. The low maternal mortality is related to the large‐scale development of standardized maternal health care in China. For severe hypertensive disorder patients, gestation should be prolonged to 32 weeks as often as possible for better neonatal survival rates.

17 February 2020 in Journal of Human Hypertension
Verified
Journal Article
Closed access
PDF file
XLXun Li
Xun Li
WZWeishe Zhang
Weishe Zhang
JLJianhua Lin
Jianhua Lin
HLHuai Liu
Huai Liu
ZYZujing Yang
Zujing Yang
SDSi Duan
Si Duan